Bioresorbable laryngotracheal stent and methods of treatment

Patent metadata

Field	Value
Publication number	US-9549806-B2
Application number	US-201414458121-A
Country	US
Kind code	B2
Filing date	Aug 12, 2014
Priority date	Aug 12, 2013
Publication date	Jan 24, 2017
Grant date	Jan 24, 2017

Abstract

Bioresorbable stents for treating airway disorders and methods of treatment of the airway disorders using the bioresorbable stents are disclosed. Once implanted, the stents stabilize or maintain an airway lumen. The radial strength of the stents decreases with time which allows the airway to adjust from being artificially supported to a healed state without artificial support. The stent may be removed from the airway through bioresorption without intervention. The bioresorbable stents include a bioresorbable body having a shape that conforms or is conformable to the shape of the of airway lumen.

First claim

What is claimed is:

1. A method of treating an airway disorder in a patient in need of treatment thereof, comprising:
providing a bioresorbable non-expandable stent; and
maintaining an airway in a desired configuration by disposing the stent within the airway of a patient having an airway disorder,
wherein an initial radial strength of the stent allows it to maintain the desired configuration of the airway to allow healing of the airway,
wherein the radial strength of the stent decreases with time due to bioresorption of the stent allowing the airway to adjust from being artificially supported to a healed state without artificial support of the stent; and
removing the stent from the airway at a prescribed time point through intervention after disposing the stent within the airway, wherein the stent is designed to have adequate axial strength at the prescribed time point to allow removal of the stent.

2. The method of claim 1 , wherein the airway is selected from the group consisting of pharynx, larynx, and trachea.

3. The method of claim 1 , wherein the stent comprises a variable diameter that conforms to the geometry of the airway.

4. The method of claim 1 , wherein the airway disorder is selected from the group consisting of laryngotracheal stenosis, glottic stenosis, subglottic stenosis, bronchogenic tumors, tracheomalacia, bronchomalacia, tracheal trauma, a tracheal lesion, and stenosis that occurs following the resection of lesions in the airway.

5. A method of treating an airway disorder in a patient in need of treatment thereof, comprising:
providing a bioresorbable radially expandable bioresorbable scaffold in a reduced delivery configuration mounted over a balloon;
delivering the scaffold to an implant site in an airway, wherein the airway has a variable diameter;
radially expanding the scaffold at the implant site within the airway by inflating the balloon; and
expanding a dilatation balloon in specific regions of the scaffold not conforming to a wall of the airway for better apposition of the scaffold to the wall of the airway such that a diameter of the scaffold varies along with the variable diameter of the airway,
wherein an initial radial strength of the scaffold allows it to maintain the airway in a desired configuration of the airway to allow healing,
wherein the radial strength of the scaffold decreases with time due to bioresorption of the scaffold allowing the airway to adjust from being artificially supported to a healed state without artificial support of the scaffold.

6. The method of claim 5 , wherein the airway is selected from the group consisting of pharynx, larynx, and trachea.

7. The method of claim 5 , wherein the expanded scaffold conforms to an airway anatomy through variable expansion of the scaffold.

8. The method of claim 5 , wherein the scaffold is not removed from the airway through intervention and is allowed to resorb completely away from the airway.

9. The method of claim 5 , wherein the airway disorder is selected from the group consisting of laryngotracheal stenosis, glottic stenosis, subglottic stenosis, bronchogenic tumors, tracheomalacia, bronchomalacia, tracheal trauma, a tracheal lesion, and stenosis that occurs following the resection of lesions in the airway.

Assignees

• Abbott Cardiovascular Systems Inc

Inventors

• Fox Julia C
• Pacetti Stephen D

Classifications

• A61L31/148

  Materials at least partially resorbable by the body · CPC title

• A61F2230/0067

  conical · CPC title

• A61F2/04 Primary

  Hollow or tubular parts of organs, e.g. bladders, tracheae, bronchi or bile ducts (A61F2/18, A61F2/20 take precedence; instruments specially adapted for placement or removal of stents or stent-grafts A61F2/95) · CPC title

• A61F2/20

  Larynxes; Tracheae combined with larynxes or for use therewith · CPC title

• A61F2/82

  Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents (stent-grafts for tubular structures of the body other than blood vessels A61F2/04; stent-grafts for blood vessels A61F2/07) · CPC title